CARFILZOMIB | CARFILZOMIB | ATC L01XG02
ANTINEOPLATIC TREATMENT OF MULTIPLE MYELOMA PROTEASOME INHIBITOR THAT IRREVERSIBLY (COVALENTLY) BINDS TO THE N-TERMINAL THREONINE-CONTAINING ACTIVE SITES OF THE 20S PROTEASOME | INTRAVENOUS INJECTION | Cmax 5.8 MICROMOLAR VD 28 LITER PPB 97 PERCENT Cl 207 LITER / HOUR HT 1 HOUR SOLUBILITY PRACTICALLY INSOLUBLE IN WATER | 20S PROTEASOME | Proteasome subunit beta type-5 UNIPROT P28074 PSMB5 more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |